Aa
Aa
A
A
A
Close
Avatar universal

Johnson & Johnson acquired Novira Therapeutics

Johnson & Johnson announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.  The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778.  Financial terms of the transaction have not been disclosed.

http://www.marketwatch.com/story/johnson-johnson-announces-agreement-to-acquire-novira-therapeutics-inc-2015-11-04

More and More competition its always good. what do you thing of novira's NVR 3-778? do you think it might contribute to a final cure?
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
i think still they are in phase "Produces Deep and Durable Knockdown" so they are far from contributing a cure.
Helpful - 0
Avatar universal
Havent read the link the only way to determine weather its good or not is dependant on which direction johnson and johnson take the company only time will really tell
Helpful - 0
Have an Answer?

You are reading content posted in the Hepatitis B Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
Can I get HIV from surfaces, like toilet seats?